Global Transthyretin Amyloidosis Drug Production, Demand and Key Producers, 2022-2028
Transthyretin amyloidosis is a slowly progressive disease in which abnormal deposits of a protein called amyloid occur in the body's organs and tissues of the person. It is a progressive and fatal rare disease that can destroy nerve cells. It is often considered difficult to recognize and diagnose properly, and treatment is generally critical. However, the most common symptoms include heart failure, chronic diarrhea, weight loss, dry mouth, constipation, carpal tunnel syndrome, impaired kidney function, and floaters.
This report studies the global Transthyretin Amyloidosis Drug production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Transthyretin Amyloidosis Drug, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2021 as the base year. This report explores demand trends and competition, as well as details the characteristics of Transthyretin Amyloidosis Drug that contribute to its increasing demand across many markets.
The global Transthyretin Amyloidosis Drug market size is expected to reach $ million by 2028, rising at a market growth of % CAGR during the forecast period (2022-2028).
Highlights and key features of the study
Global Transthyretin Amyloidosis Drug total production and demand, 2017-2028, (K Units)
Global Transthyretin Amyloidosis Drug total production value, 2017-2028, (USD Million)
Global Transthyretin Amyloidosis Drug production by region & country, production, value, CAGR, 2017-2028, (USD Million) & (K Units)
Global Transthyretin Amyloidosis Drug consumption by region & country, CAGR, 2017-2028 & (K Units)
U.S. VS China: Transthyretin Amyloidosis Drug domestic production, consumption, key domestic manufacturers and share
Global Transthyretin Amyloidosis Drug production by manufacturer, production, price, value and market share 2017-2022, (USD Million) & (K Units)
Global Transthyretin Amyloidosis Drug production by Type, production, value, CAGR, 2017-2028, (USD Million) & (K Units)
Global Transthyretin Amyloidosis Drug production by Application production, value, CAGR, 2017-2028, (USD Million) & (K Units)
This reports profiles key players in the global Transthyretin Amyloidosis Drug market based on the following parameters – headquarters, production locations, products portfolio, Transthyretin Amyloidosis Drug revenue, sales, average price and gross margin, recent developments.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Transthyretin Amyloidosis Drug market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2017-2028 by year with 2021 as the base year, 2022 as the estimate year, and 2028 as the forecast year.
Global Transthyretin Amyloidosis Drug Market, By Region:
1. How big is the global Transthyretin Amyloidosis Drug market?
2. What is the demand of the global Transthyretin Amyloidosis Drug market?
3. What is the year over year growth of the global Transthyretin Amyloidosis Drug market?
4. What is the production and production value of the global Transthyretin Amyloidosis Drug market?
5. Who are the key producers in the global Transthyretin Amyloidosis Drug market?
6. What are the growth factors driving the market demand?
This report studies the global Transthyretin Amyloidosis Drug production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Transthyretin Amyloidosis Drug, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2021 as the base year. This report explores demand trends and competition, as well as details the characteristics of Transthyretin Amyloidosis Drug that contribute to its increasing demand across many markets.
The global Transthyretin Amyloidosis Drug market size is expected to reach $ million by 2028, rising at a market growth of % CAGR during the forecast period (2022-2028).
Highlights and key features of the study
Global Transthyretin Amyloidosis Drug total production and demand, 2017-2028, (K Units)
Global Transthyretin Amyloidosis Drug total production value, 2017-2028, (USD Million)
Global Transthyretin Amyloidosis Drug production by region & country, production, value, CAGR, 2017-2028, (USD Million) & (K Units)
Global Transthyretin Amyloidosis Drug consumption by region & country, CAGR, 2017-2028 & (K Units)
U.S. VS China: Transthyretin Amyloidosis Drug domestic production, consumption, key domestic manufacturers and share
Global Transthyretin Amyloidosis Drug production by manufacturer, production, price, value and market share 2017-2022, (USD Million) & (K Units)
Global Transthyretin Amyloidosis Drug production by Type, production, value, CAGR, 2017-2028, (USD Million) & (K Units)
Global Transthyretin Amyloidosis Drug production by Application production, value, CAGR, 2017-2028, (USD Million) & (K Units)
This reports profiles key players in the global Transthyretin Amyloidosis Drug market based on the following parameters – headquarters, production locations, products portfolio, Transthyretin Amyloidosis Drug revenue, sales, average price and gross margin, recent developments.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Transthyretin Amyloidosis Drug market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2017-2028 by year with 2021 as the base year, 2022 as the estimate year, and 2028 as the forecast year.
Global Transthyretin Amyloidosis Drug Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Tafamidis
- Patisiran
- Inotersen
- Other
- Hereditary Transthyretin Amyloidosis
- Wild Transthyretin Amyloidosis
- Pfizer Inc
- AstraZeneca
- Prothena Corporation plc
- Ionis Pharmaceuticals
- BELLUS Health Inc
- Alnylam Pharmaceuticals, Inc
- Eidos Therapeutics, Inc
- SOM BIOTECH
- Abbvie, Inc
- Bausch Health Companies Inc
- Bristol Myers Squibb Company
- GSK Plc
- Merck KGaA
- Sanofi
1. How big is the global Transthyretin Amyloidosis Drug market?
2. What is the demand of the global Transthyretin Amyloidosis Drug market?
3. What is the year over year growth of the global Transthyretin Amyloidosis Drug market?
4. What is the production and production value of the global Transthyretin Amyloidosis Drug market?
5. Who are the key producers in the global Transthyretin Amyloidosis Drug market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Transthyretin Amyloidosis Drug Introduction
1.2 World Transthyretin Amyloidosis Drug Supply & Forecast
1.2.1 World Transthyretin Amyloidosis Drug Production Value (2017 & 2021 & 2028)
1.2.2 World Transthyretin Amyloidosis Drug Production (2017-2028)
1.2.3 World Transthyretin Amyloidosis Drug Pricing Trends (2017-2028)
1.3 World Transthyretin Amyloidosis Drug Production by Region
1.3.1 World Transthyretin Amyloidosis Drug Production Value by Region (2017-2028)
1.3.2 World Transthyretin Amyloidosis Drug Production by Region (2017-2028)
1.3.3 World Transthyretin Amyloidosis Drug Average Price by Region (2017-2028)
1.3.4 North America Transthyretin Amyloidosis Drug Production (2017-2028)
1.3.5 Europe Transthyretin Amyloidosis Drug Production (2017-2028)
1.3.6 China Transthyretin Amyloidosis Drug Production (2017-2028)
1.3.7 Japan Transthyretin Amyloidosis Drug Production (2017-2028)
1.4 Market Drivers, Restraints and Trends
1.4.1 Transthyretin Amyloidosis Drug Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Transthyretin Amyloidosis Drug Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Transthyretin Amyloidosis Drug Demand (2017-2028)
2.2 World Transthyretin Amyloidosis Drug Consumption by Region
2.2.1 World Transthyretin Amyloidosis Drug Consumption by Region (2017-2022)
2.2.2 World Transthyretin Amyloidosis Drug Consumption Forecast by Region (2023-2028)
2.3 United States Transthyretin Amyloidosis Drug Consumption (2017-2028)
2.4 China Transthyretin Amyloidosis Drug Consumption (2017-2028)
2.5 Europe Transthyretin Amyloidosis Drug Consumption (2017-2028)
2.6 Japan Transthyretin Amyloidosis Drug Consumption (2017-2028)
2.7 South Korea Transthyretin Amyloidosis Drug Consumption (2017-2028)
2.8 ASEAN Transthyretin Amyloidosis Drug Consumption (2017-2028)
2.9 India Transthyretin Amyloidosis Drug Consumption (2017-2028)
3 WORLD TRANSTHYRETIN AMYLOIDOSIS DRUG MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Transthyretin Amyloidosis Drug Production Value by Manufacturer (2017-2022)
3.2 World Transthyretin Amyloidosis Drug Production by Manufacturer (2017-2022)
3.3 World Transthyretin Amyloidosis Drug Average Price by Manufacturer (2017-2022)
3.4 Transthyretin Amyloidosis Drug Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Transthyretin Amyloidosis Drug Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Transthyretin Amyloidosis Drug in 2021
3.5.3 Global Concentration Ratios (CR8) for Transthyretin Amyloidosis Drug in 2021
3.6 Transthyretin Amyloidosis Drug Market: Overall Company Footprint Analysis
3.6.1 Transthyretin Amyloidosis Drug Market: Region Footprint
3.6.2 Transthyretin Amyloidosis Drug Market: Company Product Type Footprint
3.6.3 Transthyretin Amyloidosis Drug Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Transthyretin Amyloidosis Drug Production Value Comparison
4.1.1 United States VS China: Transthyretin Amyloidosis Drug Production Value Comparison (2017 & 2021 & 2028)
4.1.2 United States VS China: Transthyretin Amyloidosis Drug Production Value Market Share Comparison (2017 & 2021 & 2028)
4.2 United States VS China: Transthyretin Amyloidosis Drug Production Comparison
4.2.1 United States VS China: Transthyretin Amyloidosis Drug Production Comparison (2017 & 2021 & 2028)
4.2.2 United States VS China: Transthyretin Amyloidosis Drug Production Market Share Comparison (2017 & 2021 & 2028)
4.3 United States VS China: Transthyretin Amyloidosis Drug Consumption Comparison
4.3.1 United States VS China: Transthyretin Amyloidosis Drug Consumption Comparison (2017 & 2021 & 2028)
4.3.2 United States VS China: Transthyretin Amyloidosis Drug Consumption Market Share Comparison (2017 & 2021 & 2028)
4.4 United States Transthyretin Amyloidosis Drug Key Producers and Market Share, 2017-2022
4.4.1 Major Manufacturer of Transthyretin Amyloidosis Drug in United States, Company Headquarters and Production Place (States, Country)
4.4.2 United States Transthyretin Amyloidosis Drug Production Value by Domestic Manufacturer, (2017-2022)
4.4.3 United States Transthyretin Amyloidosis Drug Production by Domestic Manufacturer, (2017-2022)
4.5 China Transthyretin Amyloidosis Drug Key Producers and Market Share, 2017-2022
4.5.1 Major Manufacturer of Transthyretin Amyloidosis Drug in China, Company Headquarters and Production Place (Province, Country)
4.5.2 China Transthyretin Amyloidosis Drug Production Value by Domestic Manufacturer, (2017-2022)
4.5.3 China Transthyretin Amyloidosis Drug Production by Domestic Manufacturer, (2017-2022)
4.6 Rest of World Transthyretin Amyloidosis Drug Key Producers and Market Share, 2017-2022
4.6.1 Major Manufacturer of Transthyretin Amyloidosis Drug in Rest of World, Company Headquarters and Production Place (State, Country)
4.6.2 Rest of World Transthyretin Amyloidosis Drug Production Value by Domestic Manufacturer, (2017-2022)
4.6.3 Rest of World Transthyretin Amyloidosis Drug Production by Domestic Manufacturer, (2017-2022)
5 MARKET ANALYSIS BY TYPE
5.1 World Transthyretin Amyloidosis Drug Market Size Overview by Type: 2017 VS 2021 VS 2028
5.2 Segment Introduction by Type
5.2.1 Tafamidis
5.2.2 Patisiran
5.2.3 Inotersen
5.2.4 Other
5.3 Market Segment by Type
5.3.1 World Transthyretin Amyloidosis Drug Production by Type (2017-2028)
5.3.2 World Transthyretin Amyloidosis Drug Production Value by Type (2017-2028)
5.3.3 World Transthyretin Amyloidosis Drug Average Price by Type (2017-2028)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Transthyretin Amyloidosis Drug Market Size Overview by Application: 2017 VS 2021 VS 2028
6.2 Segment Introduction by Application
6.2.1 Hereditary Transthyretin Amyloidosis
6.2.2 Wild Transthyretin Amyloidosis
6.3 Market Segment by Application
6.3.1 World Transthyretin Amyloidosis Drug Production by Application (2017-2028)
6.3.2 World Transthyretin Amyloidosis Drug Production Value by Application (2017-2028)
6.3.3 World Transthyretin Amyloidosis Drug Average Price by Application (2017-2028)
7 COMPANY PROFILES
7.1 Pfizer Inc
7.1.1 Pfizer Inc Details
7.1.2 Pfizer Inc Major Business
7.1.3 Pfizer Inc Transthyretin Amyloidosis Drug Product and Services
7.1.4 Pfizer Inc Transthyretin Amyloidosis Drug Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.1.5 Pfizer Inc Recent Developments/Updates
7.1.6 Pfizer Inc Competitive Strengths & Weaknesses
7.2 AstraZeneca
7.2.1 AstraZeneca Details
7.2.2 AstraZeneca Major Business
7.2.3 AstraZeneca Transthyretin Amyloidosis Drug Product and Services
7.2.4 AstraZeneca Transthyretin Amyloidosis Drug Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.2.5 AstraZeneca Recent Developments/Updates
7.2.6 AstraZeneca Competitive Strengths & Weaknesses
7.3 Prothena Corporation plc
7.3.1 Prothena Corporation plc Details
7.3.2 Prothena Corporation plc Major Business
7.3.3 Prothena Corporation plc Transthyretin Amyloidosis Drug Product and Services
7.3.4 Prothena Corporation plc Transthyretin Amyloidosis Drug Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.3.5 Prothena Corporation plc Recent Developments/Updates
7.3.6 Prothena Corporation plc Competitive Strengths & Weaknesses
7.4 Ionis Pharmaceuticals
7.4.1 Ionis Pharmaceuticals Details
7.4.2 Ionis Pharmaceuticals Major Business
7.4.3 Ionis Pharmaceuticals Transthyretin Amyloidosis Drug Product and Services
7.4.4 Ionis Pharmaceuticals Transthyretin Amyloidosis Drug Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.4.5 Ionis Pharmaceuticals Recent Developments/Updates
7.4.6 Ionis Pharmaceuticals Competitive Strengths & Weaknesses
7.5 BELLUS Health Inc
7.5.1 BELLUS Health Inc Details
7.5.2 BELLUS Health Inc Major Business
7.5.3 BELLUS Health Inc Transthyretin Amyloidosis Drug Product and Services
7.5.4 BELLUS Health Inc Transthyretin Amyloidosis Drug Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.5.5 BELLUS Health Inc Recent Developments/Updates
7.5.6 BELLUS Health Inc Competitive Strengths & Weaknesses
7.6 Alnylam Pharmaceuticals, Inc
7.6.1 Alnylam Pharmaceuticals, Inc Details
7.6.2 Alnylam Pharmaceuticals, Inc Major Business
7.6.3 Alnylam Pharmaceuticals, Inc Transthyretin Amyloidosis Drug Product and Services
7.6.4 Alnylam Pharmaceuticals, Inc Transthyretin Amyloidosis Drug Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.6.5 Alnylam Pharmaceuticals, Inc Recent Developments/Updates
7.6.6 Alnylam Pharmaceuticals, Inc Competitive Strengths & Weaknesses
7.7 Eidos Therapeutics, Inc
7.7.1 Eidos Therapeutics, Inc Details
7.7.2 Eidos Therapeutics, Inc Major Business
7.7.3 Eidos Therapeutics, Inc Transthyretin Amyloidosis Drug Product and Services
7.7.4 Eidos Therapeutics, Inc Transthyretin Amyloidosis Drug Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.7.5 Eidos Therapeutics, Inc Recent Developments/Updates
7.7.6 Eidos Therapeutics, Inc Competitive Strengths & Weaknesses
7.8 SOM BIOTECH
7.8.1 SOM BIOTECH Details
7.8.2 SOM BIOTECH Major Business
7.8.3 SOM BIOTECH Transthyretin Amyloidosis Drug Product and Services
7.8.4 SOM BIOTECH Transthyretin Amyloidosis Drug Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.8.5 SOM BIOTECH Recent Developments/Updates
7.8.6 SOM BIOTECH Competitive Strengths & Weaknesses
7.9 Abbvie, Inc
7.9.1 Abbvie, Inc Details
7.9.2 Abbvie, Inc Major Business
7.9.3 Abbvie, Inc Transthyretin Amyloidosis Drug Product and Services
7.9.4 Abbvie, Inc Transthyretin Amyloidosis Drug Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.9.5 Abbvie, Inc Recent Developments/Updates
7.9.6 Abbvie, Inc Competitive Strengths & Weaknesses
7.10 Bausch Health Companies Inc
7.10.1 Bausch Health Companies Inc Details
7.10.2 Bausch Health Companies Inc Major Business
7.10.3 Bausch Health Companies Inc Transthyretin Amyloidosis Drug Product and Services
7.10.4 Bausch Health Companies Inc Transthyretin Amyloidosis Drug Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.10.5 Bausch Health Companies Inc Recent Developments/Updates
7.10.6 Bausch Health Companies Inc Competitive Strengths & Weaknesses
7.11 Bristol Myers Squibb Company
7.11.1 Bristol Myers Squibb Company Details
7.11.2 Bristol Myers Squibb Company Major Business
7.11.3 Bristol Myers Squibb Company Transthyretin Amyloidosis Drug Product and Services
7.11.4 Bristol Myers Squibb Company Transthyretin Amyloidosis Drug Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.11.5 Bristol Myers Squibb Company Recent Developments/Updates
7.11.6 Bristol Myers Squibb Company Competitive Strengths & Weaknesses
7.12 GSK Plc
7.12.1 GSK Plc Details
7.12.2 GSK Plc Major Business
7.12.3 GSK Plc Transthyretin Amyloidosis Drug Product and Services
7.12.4 GSK Plc Transthyretin Amyloidosis Drug Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.12.5 GSK Plc Recent Developments/Updates
7.12.6 GSK Plc Competitive Strengths & Weaknesses
7.13 Merck KGaA
7.13.1 Merck KGaA Details
7.13.2 Merck KGaA Major Business
7.13.3 Merck KGaA Transthyretin Amyloidosis Drug Product and Services
7.13.4 Merck KGaA Transthyretin Amyloidosis Drug Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.13.5 Merck KGaA Recent Developments/Updates
7.13.6 Merck KGaA Competitive Strengths & Weaknesses
7.14 Sanofi
7.14.1 Sanofi Details
7.14.2 Sanofi Major Business
7.14.3 Sanofi Transthyretin Amyloidosis Drug Product and Services
7.14.4 Sanofi Transthyretin Amyloidosis Drug Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.14.5 Sanofi Recent Developments/Updates
7.14.6 Sanofi Competitive Strengths & Weaknesses
8 RAW MATERIAL AND INDUSTRY CHAIN
8.1 Raw Material of Transthyretin Amyloidosis Drug and Key Manufacturers
8.2 Transthyretin Amyloidosis Drug Manufacturing Costs
8.3 Transthyretin Amyloidosis Drug Production Process
8.4 Transthyretin Amyloidosis Drug Industrial Chain
9 DISTRIBUTION CHANNEL ANALYSIS
9.1 Distribution Channel Breakdown for Transthyretin Amyloidosis Drug Shipments (%): 2017-2028
9.1.1 Direct Channel
9.1.2 Indirect Channel
9.2 Transthyretin Amyloidosis Drug Typical Distributors
9.3 Transthyretin Amyloidosis Drug Typical Customers
10 RESEARCH FINDINGS AND CONCLUSION
11 APPENDIX
11.1 Methodology
11.2 Research Process and Data Source
11.3 Disclaimer
1.1 Transthyretin Amyloidosis Drug Introduction
1.2 World Transthyretin Amyloidosis Drug Supply & Forecast
1.2.1 World Transthyretin Amyloidosis Drug Production Value (2017 & 2021 & 2028)
1.2.2 World Transthyretin Amyloidosis Drug Production (2017-2028)
1.2.3 World Transthyretin Amyloidosis Drug Pricing Trends (2017-2028)
1.3 World Transthyretin Amyloidosis Drug Production by Region
1.3.1 World Transthyretin Amyloidosis Drug Production Value by Region (2017-2028)
1.3.2 World Transthyretin Amyloidosis Drug Production by Region (2017-2028)
1.3.3 World Transthyretin Amyloidosis Drug Average Price by Region (2017-2028)
1.3.4 North America Transthyretin Amyloidosis Drug Production (2017-2028)
1.3.5 Europe Transthyretin Amyloidosis Drug Production (2017-2028)
1.3.6 China Transthyretin Amyloidosis Drug Production (2017-2028)
1.3.7 Japan Transthyretin Amyloidosis Drug Production (2017-2028)
1.4 Market Drivers, Restraints and Trends
1.4.1 Transthyretin Amyloidosis Drug Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Transthyretin Amyloidosis Drug Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Transthyretin Amyloidosis Drug Demand (2017-2028)
2.2 World Transthyretin Amyloidosis Drug Consumption by Region
2.2.1 World Transthyretin Amyloidosis Drug Consumption by Region (2017-2022)
2.2.2 World Transthyretin Amyloidosis Drug Consumption Forecast by Region (2023-2028)
2.3 United States Transthyretin Amyloidosis Drug Consumption (2017-2028)
2.4 China Transthyretin Amyloidosis Drug Consumption (2017-2028)
2.5 Europe Transthyretin Amyloidosis Drug Consumption (2017-2028)
2.6 Japan Transthyretin Amyloidosis Drug Consumption (2017-2028)
2.7 South Korea Transthyretin Amyloidosis Drug Consumption (2017-2028)
2.8 ASEAN Transthyretin Amyloidosis Drug Consumption (2017-2028)
2.9 India Transthyretin Amyloidosis Drug Consumption (2017-2028)
3 WORLD TRANSTHYRETIN AMYLOIDOSIS DRUG MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Transthyretin Amyloidosis Drug Production Value by Manufacturer (2017-2022)
3.2 World Transthyretin Amyloidosis Drug Production by Manufacturer (2017-2022)
3.3 World Transthyretin Amyloidosis Drug Average Price by Manufacturer (2017-2022)
3.4 Transthyretin Amyloidosis Drug Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Transthyretin Amyloidosis Drug Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Transthyretin Amyloidosis Drug in 2021
3.5.3 Global Concentration Ratios (CR8) for Transthyretin Amyloidosis Drug in 2021
3.6 Transthyretin Amyloidosis Drug Market: Overall Company Footprint Analysis
3.6.1 Transthyretin Amyloidosis Drug Market: Region Footprint
3.6.2 Transthyretin Amyloidosis Drug Market: Company Product Type Footprint
3.6.3 Transthyretin Amyloidosis Drug Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Transthyretin Amyloidosis Drug Production Value Comparison
4.1.1 United States VS China: Transthyretin Amyloidosis Drug Production Value Comparison (2017 & 2021 & 2028)
4.1.2 United States VS China: Transthyretin Amyloidosis Drug Production Value Market Share Comparison (2017 & 2021 & 2028)
4.2 United States VS China: Transthyretin Amyloidosis Drug Production Comparison
4.2.1 United States VS China: Transthyretin Amyloidosis Drug Production Comparison (2017 & 2021 & 2028)
4.2.2 United States VS China: Transthyretin Amyloidosis Drug Production Market Share Comparison (2017 & 2021 & 2028)
4.3 United States VS China: Transthyretin Amyloidosis Drug Consumption Comparison
4.3.1 United States VS China: Transthyretin Amyloidosis Drug Consumption Comparison (2017 & 2021 & 2028)
4.3.2 United States VS China: Transthyretin Amyloidosis Drug Consumption Market Share Comparison (2017 & 2021 & 2028)
4.4 United States Transthyretin Amyloidosis Drug Key Producers and Market Share, 2017-2022
4.4.1 Major Manufacturer of Transthyretin Amyloidosis Drug in United States, Company Headquarters and Production Place (States, Country)
4.4.2 United States Transthyretin Amyloidosis Drug Production Value by Domestic Manufacturer, (2017-2022)
4.4.3 United States Transthyretin Amyloidosis Drug Production by Domestic Manufacturer, (2017-2022)
4.5 China Transthyretin Amyloidosis Drug Key Producers and Market Share, 2017-2022
4.5.1 Major Manufacturer of Transthyretin Amyloidosis Drug in China, Company Headquarters and Production Place (Province, Country)
4.5.2 China Transthyretin Amyloidosis Drug Production Value by Domestic Manufacturer, (2017-2022)
4.5.3 China Transthyretin Amyloidosis Drug Production by Domestic Manufacturer, (2017-2022)
4.6 Rest of World Transthyretin Amyloidosis Drug Key Producers and Market Share, 2017-2022
4.6.1 Major Manufacturer of Transthyretin Amyloidosis Drug in Rest of World, Company Headquarters and Production Place (State, Country)
4.6.2 Rest of World Transthyretin Amyloidosis Drug Production Value by Domestic Manufacturer, (2017-2022)
4.6.3 Rest of World Transthyretin Amyloidosis Drug Production by Domestic Manufacturer, (2017-2022)
5 MARKET ANALYSIS BY TYPE
5.1 World Transthyretin Amyloidosis Drug Market Size Overview by Type: 2017 VS 2021 VS 2028
5.2 Segment Introduction by Type
5.2.1 Tafamidis
5.2.2 Patisiran
5.2.3 Inotersen
5.2.4 Other
5.3 Market Segment by Type
5.3.1 World Transthyretin Amyloidosis Drug Production by Type (2017-2028)
5.3.2 World Transthyretin Amyloidosis Drug Production Value by Type (2017-2028)
5.3.3 World Transthyretin Amyloidosis Drug Average Price by Type (2017-2028)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Transthyretin Amyloidosis Drug Market Size Overview by Application: 2017 VS 2021 VS 2028
6.2 Segment Introduction by Application
6.2.1 Hereditary Transthyretin Amyloidosis
6.2.2 Wild Transthyretin Amyloidosis
6.3 Market Segment by Application
6.3.1 World Transthyretin Amyloidosis Drug Production by Application (2017-2028)
6.3.2 World Transthyretin Amyloidosis Drug Production Value by Application (2017-2028)
6.3.3 World Transthyretin Amyloidosis Drug Average Price by Application (2017-2028)
7 COMPANY PROFILES
7.1 Pfizer Inc
7.1.1 Pfizer Inc Details
7.1.2 Pfizer Inc Major Business
7.1.3 Pfizer Inc Transthyretin Amyloidosis Drug Product and Services
7.1.4 Pfizer Inc Transthyretin Amyloidosis Drug Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.1.5 Pfizer Inc Recent Developments/Updates
7.1.6 Pfizer Inc Competitive Strengths & Weaknesses
7.2 AstraZeneca
7.2.1 AstraZeneca Details
7.2.2 AstraZeneca Major Business
7.2.3 AstraZeneca Transthyretin Amyloidosis Drug Product and Services
7.2.4 AstraZeneca Transthyretin Amyloidosis Drug Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.2.5 AstraZeneca Recent Developments/Updates
7.2.6 AstraZeneca Competitive Strengths & Weaknesses
7.3 Prothena Corporation plc
7.3.1 Prothena Corporation plc Details
7.3.2 Prothena Corporation plc Major Business
7.3.3 Prothena Corporation plc Transthyretin Amyloidosis Drug Product and Services
7.3.4 Prothena Corporation plc Transthyretin Amyloidosis Drug Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.3.5 Prothena Corporation plc Recent Developments/Updates
7.3.6 Prothena Corporation plc Competitive Strengths & Weaknesses
7.4 Ionis Pharmaceuticals
7.4.1 Ionis Pharmaceuticals Details
7.4.2 Ionis Pharmaceuticals Major Business
7.4.3 Ionis Pharmaceuticals Transthyretin Amyloidosis Drug Product and Services
7.4.4 Ionis Pharmaceuticals Transthyretin Amyloidosis Drug Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.4.5 Ionis Pharmaceuticals Recent Developments/Updates
7.4.6 Ionis Pharmaceuticals Competitive Strengths & Weaknesses
7.5 BELLUS Health Inc
7.5.1 BELLUS Health Inc Details
7.5.2 BELLUS Health Inc Major Business
7.5.3 BELLUS Health Inc Transthyretin Amyloidosis Drug Product and Services
7.5.4 BELLUS Health Inc Transthyretin Amyloidosis Drug Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.5.5 BELLUS Health Inc Recent Developments/Updates
7.5.6 BELLUS Health Inc Competitive Strengths & Weaknesses
7.6 Alnylam Pharmaceuticals, Inc
7.6.1 Alnylam Pharmaceuticals, Inc Details
7.6.2 Alnylam Pharmaceuticals, Inc Major Business
7.6.3 Alnylam Pharmaceuticals, Inc Transthyretin Amyloidosis Drug Product and Services
7.6.4 Alnylam Pharmaceuticals, Inc Transthyretin Amyloidosis Drug Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.6.5 Alnylam Pharmaceuticals, Inc Recent Developments/Updates
7.6.6 Alnylam Pharmaceuticals, Inc Competitive Strengths & Weaknesses
7.7 Eidos Therapeutics, Inc
7.7.1 Eidos Therapeutics, Inc Details
7.7.2 Eidos Therapeutics, Inc Major Business
7.7.3 Eidos Therapeutics, Inc Transthyretin Amyloidosis Drug Product and Services
7.7.4 Eidos Therapeutics, Inc Transthyretin Amyloidosis Drug Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.7.5 Eidos Therapeutics, Inc Recent Developments/Updates
7.7.6 Eidos Therapeutics, Inc Competitive Strengths & Weaknesses
7.8 SOM BIOTECH
7.8.1 SOM BIOTECH Details
7.8.2 SOM BIOTECH Major Business
7.8.3 SOM BIOTECH Transthyretin Amyloidosis Drug Product and Services
7.8.4 SOM BIOTECH Transthyretin Amyloidosis Drug Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.8.5 SOM BIOTECH Recent Developments/Updates
7.8.6 SOM BIOTECH Competitive Strengths & Weaknesses
7.9 Abbvie, Inc
7.9.1 Abbvie, Inc Details
7.9.2 Abbvie, Inc Major Business
7.9.3 Abbvie, Inc Transthyretin Amyloidosis Drug Product and Services
7.9.4 Abbvie, Inc Transthyretin Amyloidosis Drug Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.9.5 Abbvie, Inc Recent Developments/Updates
7.9.6 Abbvie, Inc Competitive Strengths & Weaknesses
7.10 Bausch Health Companies Inc
7.10.1 Bausch Health Companies Inc Details
7.10.2 Bausch Health Companies Inc Major Business
7.10.3 Bausch Health Companies Inc Transthyretin Amyloidosis Drug Product and Services
7.10.4 Bausch Health Companies Inc Transthyretin Amyloidosis Drug Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.10.5 Bausch Health Companies Inc Recent Developments/Updates
7.10.6 Bausch Health Companies Inc Competitive Strengths & Weaknesses
7.11 Bristol Myers Squibb Company
7.11.1 Bristol Myers Squibb Company Details
7.11.2 Bristol Myers Squibb Company Major Business
7.11.3 Bristol Myers Squibb Company Transthyretin Amyloidosis Drug Product and Services
7.11.4 Bristol Myers Squibb Company Transthyretin Amyloidosis Drug Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.11.5 Bristol Myers Squibb Company Recent Developments/Updates
7.11.6 Bristol Myers Squibb Company Competitive Strengths & Weaknesses
7.12 GSK Plc
7.12.1 GSK Plc Details
7.12.2 GSK Plc Major Business
7.12.3 GSK Plc Transthyretin Amyloidosis Drug Product and Services
7.12.4 GSK Plc Transthyretin Amyloidosis Drug Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.12.5 GSK Plc Recent Developments/Updates
7.12.6 GSK Plc Competitive Strengths & Weaknesses
7.13 Merck KGaA
7.13.1 Merck KGaA Details
7.13.2 Merck KGaA Major Business
7.13.3 Merck KGaA Transthyretin Amyloidosis Drug Product and Services
7.13.4 Merck KGaA Transthyretin Amyloidosis Drug Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.13.5 Merck KGaA Recent Developments/Updates
7.13.6 Merck KGaA Competitive Strengths & Weaknesses
7.14 Sanofi
7.14.1 Sanofi Details
7.14.2 Sanofi Major Business
7.14.3 Sanofi Transthyretin Amyloidosis Drug Product and Services
7.14.4 Sanofi Transthyretin Amyloidosis Drug Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.14.5 Sanofi Recent Developments/Updates
7.14.6 Sanofi Competitive Strengths & Weaknesses
8 RAW MATERIAL AND INDUSTRY CHAIN
8.1 Raw Material of Transthyretin Amyloidosis Drug and Key Manufacturers
8.2 Transthyretin Amyloidosis Drug Manufacturing Costs
8.3 Transthyretin Amyloidosis Drug Production Process
8.4 Transthyretin Amyloidosis Drug Industrial Chain
9 DISTRIBUTION CHANNEL ANALYSIS
9.1 Distribution Channel Breakdown for Transthyretin Amyloidosis Drug Shipments (%): 2017-2028
9.1.1 Direct Channel
9.1.2 Indirect Channel
9.2 Transthyretin Amyloidosis Drug Typical Distributors
9.3 Transthyretin Amyloidosis Drug Typical Customers
10 RESEARCH FINDINGS AND CONCLUSION
11 APPENDIX
11.1 Methodology
11.2 Research Process and Data Source
11.3 Disclaimer
LIST OF TABLES
Table 1. World Transthyretin Amyloidosis Drug Production Value by Region (2017, 2022 and 2028) & (USD Million)
Table 2. World Transthyretin Amyloidosis Drug Production Value by Region (2017-2022) & (USD Million)
Table 3. World Transthyretin Amyloidosis Drug Production Value by Region (2023-2028) & (USD Million)
Table 4. World Transthyretin Amyloidosis Drug Production Value Market Share by Region (2017-2022)
Table 5. World Transthyretin Amyloidosis Drug Production Value Market Share by Region (2023-2028)
Table 6. World Transthyretin Amyloidosis Drug Production by Region (2017-2022) & (K Units)
Table 7. World Transthyretin Amyloidosis Drug Production by Region (2023-2028) & (K Units)
Table 8. World Transthyretin Amyloidosis Drug Production Market Share by Region (2017-2022)
Table 9. World Transthyretin Amyloidosis Drug Production Market Share by Region (2023-2028)
Table 10. World Transthyretin Amyloidosis Drug Average Price by Region (2017-2022) & (US$/Unit)
Table 11. World Transthyretin Amyloidosis Drug Average Price by Region (2023-2028) & (US$/Unit)
Table 12. Transthyretin Amyloidosis Drug Major Market Trends
Table 13. World Transthyretin Amyloidosis Drug Consumption Growth Rate Forecast by Region (2017 & 2021 & 2028) & (K Units)
Table 14. World Transthyretin Amyloidosis Drug Consumption by Region (2017-2022) & (K Units)
Table 15. World Transthyretin Amyloidosis Drug Consumption Forecast by Region (2023-2028) & (K Units)
Table 16. World Transthyretin Amyloidosis Drug Production Value by Manufacturer (2017-2022) & (USD Million)
Table 17. Production Value Market Share of Key Transthyretin Amyloidosis Drug Producers in 2021
Table 18. World Transthyretin Amyloidosis Drug Production by Manufacturer (2017-2022) & (K Units)
Table 19. Production Market Share of Key Transthyretin Amyloidosis Drug Producers in 2021
Table 20. World Transthyretin Amyloidosis Drug Average Price by Manufacturer (2017-2022) & (US$/Unit)
Table 21. Global Transthyretin Amyloidosis Drug Company Evaluation Quadrant
Table 22. World Transthyretin Amyloidosis Drug Industry Rank of Major Manufacturers, Based on Production Value in 2021
Table 23. Head Office and Transthyretin Amyloidosis Drug Production Site of Key Manufacturer
Table 24. Transthyretin Amyloidosis Drug Market: Company Product Type Footprint
Table 25. Transthyretin Amyloidosis Drug Market: Company Product Application Footprint
Table 26. Transthyretin Amyloidosis Drug Competitive Factors
Table 27. Transthyretin Amyloidosis Drug New Entrant and Capacity Expansion Plans
Table 28. Transthyretin Amyloidosis Drug Mergers & Acquisitions Activity
Table 29. United States VS China Transthyretin Amyloidosis Drug Production Value Comparison, (2017 & 2021 & 2028) & (USD Million)
Table 30. United States VS China Transthyretin Amyloidosis Drug Production Comparison, (2017 & 2021 & 2028) & (K Units)
Table 31. United States VS China Transthyretin Amyloidosis Drug Consumption Comparison, (2017 & 2021 & 2028) & (K Units)
Table 32. Major Manufacturer of Transthyretin Amyloidosis Drug in United States, Company Headquarters and Production Place (States, Country)
Table 33. United States Transthyretin Amyloidosis Drug Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 34. United States Transthyretin Amyloidosis Drug Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 35. United States Transthyretin Amyloidosis Drug Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 36. United States Transthyretin Amyloidosis Drug Production Market Share by Domestic Manufacturer, (2017-2022)
Table 37. Major Manufacturer of Transthyretin Amyloidosis Drug in China, Company Headquarters and Production Place (Province, Country)
Table 38. China Transthyretin Amyloidosis Drug Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 39. China Transthyretin Amyloidosis Drug Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 40. China Transthyretin Amyloidosis Drug Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 41. China Transthyretin Amyloidosis Drug Production Market Share by Domestic Manufacturer, (2017-2022)
Table 42. Major Manufacturer of Transthyretin Amyloidosis Drug in Rest of World, Company Headquarters and Production Place (State, Country)
Table 43. Rest of World Transthyretin Amyloidosis Drug Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 44. Rest of World Transthyretin Amyloidosis Drug Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 45. Rest of World Transthyretin Amyloidosis Drug Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 46. Rest of World Transthyretin Amyloidosis Drug Production Market Share by Domestic Manufacturer, (2017-2022)
Table 47. World Transthyretin Amyloidosis Drug Production Value by Type, (USD Million), 2017 & 2021 & 2028
Table 48. World Transthyretin Amyloidosis Drug Production by Type (2017-2022) & (K Units)
Table 49. World Transthyretin Amyloidosis Drug Production by Type (2023-2028) & (K Units)
Table 50. World Transthyretin Amyloidosis Drug Production Value by Type (2017-2022) & (USD Million)
Table 51. World Transthyretin Amyloidosis Drug Production Value by Type (2023-2028) & (USD Million)
Table 52. World Transthyretin Amyloidosis Drug Average Price by Type (2017-2022) & (US$/Unit)
Table 53. World Transthyretin Amyloidosis Drug Average Price by Type (2023-2028) & (US$/Unit)
Table 54. World Transthyretin Amyloidosis Drug Production Value by Application, (USD Million), 2017 & 2021 & 2028
Table 55. World Transthyretin Amyloidosis Drug Production by Application (2017-2022) & (K Units)
Table 56. World Transthyretin Amyloidosis Drug Production by Application (2023-2028) & (K Units)
Table 57. World Transthyretin Amyloidosis Drug Production Value by Application (2017-2022) & (USD Million)
Table 58. World Transthyretin Amyloidosis Drug Production Value by Application (2023-2028) & (USD Million)
Table 59. World Transthyretin Amyloidosis Drug Average Price by Application (2017-2022) & (US$/Unit)
Table 60. World Transthyretin Amyloidosis Drug Average Price by Application (2023-2028) & (US$/Unit)
Table 61. Pfizer Inc Basic Information, Manufacturing Base and Competitors
Table 62. Pfizer Inc Major Business
Table 63. Pfizer Inc Transthyretin Amyloidosis Drug Product and Services
Table 64. Pfizer Inc Transthyretin Amyloidosis Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 65. Pfizer Inc Recent Developments/Updates
Table 66. Pfizer Inc Competitive Strengths & Weaknesses
Table 67. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 68. AstraZeneca Major Business
Table 69. AstraZeneca Transthyretin Amyloidosis Drug Product and Services
Table 70. AstraZeneca Transthyretin Amyloidosis Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 71. AstraZeneca Recent Developments/Updates
Table 72. AstraZeneca Competitive Strengths & Weaknesses
Table 73. Prothena Corporation plc Basic Information, Manufacturing Base and Competitors
Table 74. Prothena Corporation plc Major Business
Table 75. Prothena Corporation plc Transthyretin Amyloidosis Drug Product and Services
Table 76. Prothena Corporation plc Transthyretin Amyloidosis Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 77. Prothena Corporation plc Recent Developments/Updates
Table 78. Prothena Corporation plc Competitive Strengths & Weaknesses
Table 79. Ionis Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 80. Ionis Pharmaceuticals Major Business
Table 81. Ionis Pharmaceuticals Transthyretin Amyloidosis Drug Product and Services
Table 82. Ionis Pharmaceuticals Transthyretin Amyloidosis Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 83. Ionis Pharmaceuticals Recent Developments/Updates
Table 84. Ionis Pharmaceuticals Competitive Strengths & Weaknesses
Table 85. BELLUS Health Inc Basic Information, Manufacturing Base and Competitors
Table 86. BELLUS Health Inc Major Business
Table 87. BELLUS Health Inc Transthyretin Amyloidosis Drug Product and Services
Table 88. BELLUS Health Inc Transthyretin Amyloidosis Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 89. BELLUS Health Inc Recent Developments/Updates
Table 90. BELLUS Health Inc Competitive Strengths & Weaknesses
Table 91. Alnylam Pharmaceuticals, Inc Basic Information, Manufacturing Base and Competitors
Table 92. Alnylam Pharmaceuticals, Inc Major Business
Table 93. Alnylam Pharmaceuticals, Inc Transthyretin Amyloidosis Drug Product and Services
Table 94. Alnylam Pharmaceuticals, Inc Transthyretin Amyloidosis Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 95. Alnylam Pharmaceuticals, Inc Recent Developments/Updates
Table 96. Alnylam Pharmaceuticals, Inc Competitive Strengths & Weaknesses
Table 97. Eidos Therapeutics, Inc Basic Information, Manufacturing Base and Competitors
Table 98. Eidos Therapeutics, Inc Major Business
Table 99. Eidos Therapeutics, Inc Transthyretin Amyloidosis Drug Product and Services
Table 100. Eidos Therapeutics, Inc Transthyretin Amyloidosis Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 101. Eidos Therapeutics, Inc Recent Developments/Updates
Table 102. Eidos Therapeutics, Inc Competitive Strengths & Weaknesses
Table 103. SOM BIOTECH Basic Information, Manufacturing Base and Competitors
Table 104. SOM BIOTECH Major Business
Table 105. SOM BIOTECH Transthyretin Amyloidosis Drug Product and Services
Table 106. SOM BIOTECH Transthyretin Amyloidosis Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 107. SOM BIOTECH Recent Developments/Updates
Table 108. SOM BIOTECH Competitive Strengths & Weaknesses
Table 109. Abbvie, Inc Basic Information, Manufacturing Base and Competitors
Table 110. Abbvie, Inc Major Business
Table 111. Abbvie, Inc Transthyretin Amyloidosis Drug Product and Services
Table 112. Abbvie, Inc Transthyretin Amyloidosis Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 113. Abbvie, Inc Recent Developments/Updates
Table 114. Abbvie, Inc Competitive Strengths & Weaknesses
Table 115. Bausch Health Companies Inc Basic Information, Manufacturing Base and Competitors
Table 116. Bausch Health Companies Inc Major Business
Table 117. Bausch Health Companies Inc Transthyretin Amyloidosis Drug Product and Services
Table 118. Bausch Health Companies Inc Transthyretin Amyloidosis Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 119. Bausch Health Companies Inc Recent Developments/Updates
Table 120. Bausch Health Companies Inc Competitive Strengths & Weaknesses
Table 121. Bristol Myers Squibb Company Basic Information, Manufacturing Base and Competitors
Table 122. Bristol Myers Squibb Company Major Business
Table 123. Bristol Myers Squibb Company Transthyretin Amyloidosis Drug Product and Services
Table 124. Bristol Myers Squibb Company Transthyretin Amyloidosis Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 125. Bristol Myers Squibb Company Recent Developments/Updates
Table 126. Bristol Myers Squibb Company Competitive Strengths & Weaknesses
Table 127. GSK Plc Basic Information, Manufacturing Base and Competitors
Table 128. GSK Plc Major Business
Table 129. GSK Plc Transthyretin Amyloidosis Drug Product and Services
Table 130. GSK Plc Transthyretin Amyloidosis Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 131. GSK Plc Recent Developments/Updates
Table 132. GSK Plc Competitive Strengths & Weaknesses
Table 133. Merck KGaA Basic Information, Manufacturing Base and Competitors
Table 134. Merck KGaA Major Business
Table 135. Merck KGaA Transthyretin Amyloidosis Drug Product and Services
Table 136. Merck KGaA Transthyretin Amyloidosis Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 137. Merck KGaA Recent Developments/Updates
Table 138. Sanofi Basic Information, Manufacturing Base and Competitors
Table 139. Sanofi Major Business
Table 140. Sanofi Transthyretin Amyloidosis Drug Product and Services
Table 141. Sanofi Transthyretin Amyloidosis Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 142. Transthyretin Amyloidosis Drug Raw Material
Table 143. Key Manufacturers of Transthyretin Amyloidosis Drug Raw Materials
Table 144. Transthyretin Amyloidosis Drug Typical Distributors
Table 145. Transthyretin Amyloidosis Drug Typical Customers
Table 1. World Transthyretin Amyloidosis Drug Production Value by Region (2017, 2022 and 2028) & (USD Million)
Table 2. World Transthyretin Amyloidosis Drug Production Value by Region (2017-2022) & (USD Million)
Table 3. World Transthyretin Amyloidosis Drug Production Value by Region (2023-2028) & (USD Million)
Table 4. World Transthyretin Amyloidosis Drug Production Value Market Share by Region (2017-2022)
Table 5. World Transthyretin Amyloidosis Drug Production Value Market Share by Region (2023-2028)
Table 6. World Transthyretin Amyloidosis Drug Production by Region (2017-2022) & (K Units)
Table 7. World Transthyretin Amyloidosis Drug Production by Region (2023-2028) & (K Units)
Table 8. World Transthyretin Amyloidosis Drug Production Market Share by Region (2017-2022)
Table 9. World Transthyretin Amyloidosis Drug Production Market Share by Region (2023-2028)
Table 10. World Transthyretin Amyloidosis Drug Average Price by Region (2017-2022) & (US$/Unit)
Table 11. World Transthyretin Amyloidosis Drug Average Price by Region (2023-2028) & (US$/Unit)
Table 12. Transthyretin Amyloidosis Drug Major Market Trends
Table 13. World Transthyretin Amyloidosis Drug Consumption Growth Rate Forecast by Region (2017 & 2021 & 2028) & (K Units)
Table 14. World Transthyretin Amyloidosis Drug Consumption by Region (2017-2022) & (K Units)
Table 15. World Transthyretin Amyloidosis Drug Consumption Forecast by Region (2023-2028) & (K Units)
Table 16. World Transthyretin Amyloidosis Drug Production Value by Manufacturer (2017-2022) & (USD Million)
Table 17. Production Value Market Share of Key Transthyretin Amyloidosis Drug Producers in 2021
Table 18. World Transthyretin Amyloidosis Drug Production by Manufacturer (2017-2022) & (K Units)
Table 19. Production Market Share of Key Transthyretin Amyloidosis Drug Producers in 2021
Table 20. World Transthyretin Amyloidosis Drug Average Price by Manufacturer (2017-2022) & (US$/Unit)
Table 21. Global Transthyretin Amyloidosis Drug Company Evaluation Quadrant
Table 22. World Transthyretin Amyloidosis Drug Industry Rank of Major Manufacturers, Based on Production Value in 2021
Table 23. Head Office and Transthyretin Amyloidosis Drug Production Site of Key Manufacturer
Table 24. Transthyretin Amyloidosis Drug Market: Company Product Type Footprint
Table 25. Transthyretin Amyloidosis Drug Market: Company Product Application Footprint
Table 26. Transthyretin Amyloidosis Drug Competitive Factors
Table 27. Transthyretin Amyloidosis Drug New Entrant and Capacity Expansion Plans
Table 28. Transthyretin Amyloidosis Drug Mergers & Acquisitions Activity
Table 29. United States VS China Transthyretin Amyloidosis Drug Production Value Comparison, (2017 & 2021 & 2028) & (USD Million)
Table 30. United States VS China Transthyretin Amyloidosis Drug Production Comparison, (2017 & 2021 & 2028) & (K Units)
Table 31. United States VS China Transthyretin Amyloidosis Drug Consumption Comparison, (2017 & 2021 & 2028) & (K Units)
Table 32. Major Manufacturer of Transthyretin Amyloidosis Drug in United States, Company Headquarters and Production Place (States, Country)
Table 33. United States Transthyretin Amyloidosis Drug Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 34. United States Transthyretin Amyloidosis Drug Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 35. United States Transthyretin Amyloidosis Drug Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 36. United States Transthyretin Amyloidosis Drug Production Market Share by Domestic Manufacturer, (2017-2022)
Table 37. Major Manufacturer of Transthyretin Amyloidosis Drug in China, Company Headquarters and Production Place (Province, Country)
Table 38. China Transthyretin Amyloidosis Drug Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 39. China Transthyretin Amyloidosis Drug Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 40. China Transthyretin Amyloidosis Drug Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 41. China Transthyretin Amyloidosis Drug Production Market Share by Domestic Manufacturer, (2017-2022)
Table 42. Major Manufacturer of Transthyretin Amyloidosis Drug in Rest of World, Company Headquarters and Production Place (State, Country)
Table 43. Rest of World Transthyretin Amyloidosis Drug Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 44. Rest of World Transthyretin Amyloidosis Drug Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 45. Rest of World Transthyretin Amyloidosis Drug Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 46. Rest of World Transthyretin Amyloidosis Drug Production Market Share by Domestic Manufacturer, (2017-2022)
Table 47. World Transthyretin Amyloidosis Drug Production Value by Type, (USD Million), 2017 & 2021 & 2028
Table 48. World Transthyretin Amyloidosis Drug Production by Type (2017-2022) & (K Units)
Table 49. World Transthyretin Amyloidosis Drug Production by Type (2023-2028) & (K Units)
Table 50. World Transthyretin Amyloidosis Drug Production Value by Type (2017-2022) & (USD Million)
Table 51. World Transthyretin Amyloidosis Drug Production Value by Type (2023-2028) & (USD Million)
Table 52. World Transthyretin Amyloidosis Drug Average Price by Type (2017-2022) & (US$/Unit)
Table 53. World Transthyretin Amyloidosis Drug Average Price by Type (2023-2028) & (US$/Unit)
Table 54. World Transthyretin Amyloidosis Drug Production Value by Application, (USD Million), 2017 & 2021 & 2028
Table 55. World Transthyretin Amyloidosis Drug Production by Application (2017-2022) & (K Units)
Table 56. World Transthyretin Amyloidosis Drug Production by Application (2023-2028) & (K Units)
Table 57. World Transthyretin Amyloidosis Drug Production Value by Application (2017-2022) & (USD Million)
Table 58. World Transthyretin Amyloidosis Drug Production Value by Application (2023-2028) & (USD Million)
Table 59. World Transthyretin Amyloidosis Drug Average Price by Application (2017-2022) & (US$/Unit)
Table 60. World Transthyretin Amyloidosis Drug Average Price by Application (2023-2028) & (US$/Unit)
Table 61. Pfizer Inc Basic Information, Manufacturing Base and Competitors
Table 62. Pfizer Inc Major Business
Table 63. Pfizer Inc Transthyretin Amyloidosis Drug Product and Services
Table 64. Pfizer Inc Transthyretin Amyloidosis Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 65. Pfizer Inc Recent Developments/Updates
Table 66. Pfizer Inc Competitive Strengths & Weaknesses
Table 67. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 68. AstraZeneca Major Business
Table 69. AstraZeneca Transthyretin Amyloidosis Drug Product and Services
Table 70. AstraZeneca Transthyretin Amyloidosis Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 71. AstraZeneca Recent Developments/Updates
Table 72. AstraZeneca Competitive Strengths & Weaknesses
Table 73. Prothena Corporation plc Basic Information, Manufacturing Base and Competitors
Table 74. Prothena Corporation plc Major Business
Table 75. Prothena Corporation plc Transthyretin Amyloidosis Drug Product and Services
Table 76. Prothena Corporation plc Transthyretin Amyloidosis Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 77. Prothena Corporation plc Recent Developments/Updates
Table 78. Prothena Corporation plc Competitive Strengths & Weaknesses
Table 79. Ionis Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 80. Ionis Pharmaceuticals Major Business
Table 81. Ionis Pharmaceuticals Transthyretin Amyloidosis Drug Product and Services
Table 82. Ionis Pharmaceuticals Transthyretin Amyloidosis Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 83. Ionis Pharmaceuticals Recent Developments/Updates
Table 84. Ionis Pharmaceuticals Competitive Strengths & Weaknesses
Table 85. BELLUS Health Inc Basic Information, Manufacturing Base and Competitors
Table 86. BELLUS Health Inc Major Business
Table 87. BELLUS Health Inc Transthyretin Amyloidosis Drug Product and Services
Table 88. BELLUS Health Inc Transthyretin Amyloidosis Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 89. BELLUS Health Inc Recent Developments/Updates
Table 90. BELLUS Health Inc Competitive Strengths & Weaknesses
Table 91. Alnylam Pharmaceuticals, Inc Basic Information, Manufacturing Base and Competitors
Table 92. Alnylam Pharmaceuticals, Inc Major Business
Table 93. Alnylam Pharmaceuticals, Inc Transthyretin Amyloidosis Drug Product and Services
Table 94. Alnylam Pharmaceuticals, Inc Transthyretin Amyloidosis Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 95. Alnylam Pharmaceuticals, Inc Recent Developments/Updates
Table 96. Alnylam Pharmaceuticals, Inc Competitive Strengths & Weaknesses
Table 97. Eidos Therapeutics, Inc Basic Information, Manufacturing Base and Competitors
Table 98. Eidos Therapeutics, Inc Major Business
Table 99. Eidos Therapeutics, Inc Transthyretin Amyloidosis Drug Product and Services
Table 100. Eidos Therapeutics, Inc Transthyretin Amyloidosis Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 101. Eidos Therapeutics, Inc Recent Developments/Updates
Table 102. Eidos Therapeutics, Inc Competitive Strengths & Weaknesses
Table 103. SOM BIOTECH Basic Information, Manufacturing Base and Competitors
Table 104. SOM BIOTECH Major Business
Table 105. SOM BIOTECH Transthyretin Amyloidosis Drug Product and Services
Table 106. SOM BIOTECH Transthyretin Amyloidosis Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 107. SOM BIOTECH Recent Developments/Updates
Table 108. SOM BIOTECH Competitive Strengths & Weaknesses
Table 109. Abbvie, Inc Basic Information, Manufacturing Base and Competitors
Table 110. Abbvie, Inc Major Business
Table 111. Abbvie, Inc Transthyretin Amyloidosis Drug Product and Services
Table 112. Abbvie, Inc Transthyretin Amyloidosis Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 113. Abbvie, Inc Recent Developments/Updates
Table 114. Abbvie, Inc Competitive Strengths & Weaknesses
Table 115. Bausch Health Companies Inc Basic Information, Manufacturing Base and Competitors
Table 116. Bausch Health Companies Inc Major Business
Table 117. Bausch Health Companies Inc Transthyretin Amyloidosis Drug Product and Services
Table 118. Bausch Health Companies Inc Transthyretin Amyloidosis Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 119. Bausch Health Companies Inc Recent Developments/Updates
Table 120. Bausch Health Companies Inc Competitive Strengths & Weaknesses
Table 121. Bristol Myers Squibb Company Basic Information, Manufacturing Base and Competitors
Table 122. Bristol Myers Squibb Company Major Business
Table 123. Bristol Myers Squibb Company Transthyretin Amyloidosis Drug Product and Services
Table 124. Bristol Myers Squibb Company Transthyretin Amyloidosis Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 125. Bristol Myers Squibb Company Recent Developments/Updates
Table 126. Bristol Myers Squibb Company Competitive Strengths & Weaknesses
Table 127. GSK Plc Basic Information, Manufacturing Base and Competitors
Table 128. GSK Plc Major Business
Table 129. GSK Plc Transthyretin Amyloidosis Drug Product and Services
Table 130. GSK Plc Transthyretin Amyloidosis Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 131. GSK Plc Recent Developments/Updates
Table 132. GSK Plc Competitive Strengths & Weaknesses
Table 133. Merck KGaA Basic Information, Manufacturing Base and Competitors
Table 134. Merck KGaA Major Business
Table 135. Merck KGaA Transthyretin Amyloidosis Drug Product and Services
Table 136. Merck KGaA Transthyretin Amyloidosis Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 137. Merck KGaA Recent Developments/Updates
Table 138. Sanofi Basic Information, Manufacturing Base and Competitors
Table 139. Sanofi Major Business
Table 140. Sanofi Transthyretin Amyloidosis Drug Product and Services
Table 141. Sanofi Transthyretin Amyloidosis Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 142. Transthyretin Amyloidosis Drug Raw Material
Table 143. Key Manufacturers of Transthyretin Amyloidosis Drug Raw Materials
Table 144. Transthyretin Amyloidosis Drug Typical Distributors
Table 145. Transthyretin Amyloidosis Drug Typical Customers
LIST OF FIGURES
Figure 1. Transthyretin Amyloidosis Drug Picture
Figure 2. World Transthyretin Amyloidosis Drug Production Value: 2017 & 2021 & 2028, (USD Million)
Figure 3. World Transthyretin Amyloidosis Drug Production Value and Forecast (2017-2028) & (USD Million)
Figure 4. World Transthyretin Amyloidosis Drug Production (2017-2028) & (K Units)
Figure 5. World Transthyretin Amyloidosis Drug Average Price (2017-2028) & (US$/Unit)
Figure 6. World Transthyretin Amyloidosis Drug Production Value Market Share by Region (2017-2028)
Figure 7. World Transthyretin Amyloidosis Drug Production Market Share by Region (2017-2028)
Figure 8. North America Transthyretin Amyloidosis Drug Production (2017-2028) & (K Units)
Figure 9. Europe Transthyretin Amyloidosis Drug Production (2017-2028) & (K Units)
Figure 10. China Transthyretin Amyloidosis Drug Production (2017-2028) & (K Units)
Figure 11. Japan Transthyretin Amyloidosis Drug Production (2017-2028) & (K Units)
Figure 12. Transthyretin Amyloidosis Drug Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Transthyretin Amyloidosis Drug Demand (2017-2028) & (K Units)
Figure 15. World Transthyretin Amyloidosis Drug Consumption Market Share by Region (2017-2028)
Figure 16. United States Transthyretin Amyloidosis Drug Consumption (2017-2028) & (K Units)
Figure 17. China Transthyretin Amyloidosis Drug Consumption (2017-2028) & (K Units)
Figure 18. Europe Transthyretin Amyloidosis Drug Consumption (2017-2028) & (K Units)
Figure 19. Japan Transthyretin Amyloidosis Drug Consumption (2017-2028) & (K Units)
Figure 20. South Korea Transthyretin Amyloidosis Drug Consumption (2017-2028) & (K Units)
Figure 21. ASEAN Transthyretin Amyloidosis Drug Consumption (2017-2028) & (K Units)
Figure 22. India Transthyretin Amyloidosis Drug Consumption (2017-2028) & (K Units)
Figure 23. Producer Shipments of Transthyretin Amyloidosis Drug by Manufacturer Revenue ($MM) and Market Share (%): 2021
Figure 24. Global Four-firm Concentration Ratios (CR4) for Transthyretin Amyloidosis Drug Markets in 2021
Figure 25. Global Four-firm Concentration Ratios (CR8) for Transthyretin Amyloidosis Drug Markets in 2021
Figure 26. United States VS China: Transthyretin Amyloidosis Drug Production Value Market Share Comparison (2017 & 2021 & 2028)
Figure 27. United States VS China: Transthyretin Amyloidosis Drug Production Market Share Comparison (2017 & 2021 & 2028)
Figure 28. United States VS China: Transthyretin Amyloidosis Drug Consumption Market Share Comparison (2017 & 2021 & 2028)
Figure 29. Key Producers and Market Share of Transthyretin Amyloidosis Drug in United States
Figure 30. Key Producers and Market Share of Transthyretin Amyloidosis Drug in China
Figure 31. Key Producers and Market Share of Transthyretin Amyloidosis Drug in Rest of World
Figure 32. World Transthyretin Amyloidosis Drug Production Value by Type, (USD Million), 2017 & 2021 & 2028
Figure 33. World Transthyretin Amyloidosis Drug Production Value Market Share by Type in 2021
Figure 34. Tafamidis
Figure 35. Patisiran
Figure 36. Inotersen
Figure 37. Other
Figure 38. World Transthyretin Amyloidosis Drug Production Market Share by Type (2017-2028)
Figure 39. World Transthyretin Amyloidosis Drug Production Value Market Share by Type (2017-2028)
Figure 40. World Transthyretin Amyloidosis Drug Average Price by Type (2017-2028) & (US$/Unit)
Figure 41. World Transthyretin Amyloidosis Drug Production Value by Application, (USD Million), 2017 & 2021 & 2028
Figure 42. World Transthyretin Amyloidosis Drug Production Value Market Share by Application in 2021
Figure 43. Hereditary Transthyretin Amyloidosis
Figure 44. Wild Transthyretin Amyloidosis
Figure 45. World Transthyretin Amyloidosis Drug Production Market Share by Application (2017-2028)
Figure 46. World Transthyretin Amyloidosis Drug Production Value Market Share by Application (2017-2028)
Figure 47. World Transthyretin Amyloidosis Drug Average Price by Application (2017-2028) & (US$/Unit)
Figure 48. Manufacturing Cost Structure Analysis of Transthyretin Amyloidosis Drug in 2021
Figure 49. Manufacturing Process Analysis of Transthyretin Amyloidosis Drug
Figure 50. Transthyretin Amyloidosis Drug Industrial Chain
Figure 51. Distribution Channel Breakdown for Transthyretin Amyloidosis Drug Shipments (%): 2017-2028
Figure 52. Direct Channel Pros & Cons
Figure 53. Indirect Channel Pros & Cons
Figure 54. Methodology
Figure 55. Research Process and Data Source
Figure 1. Transthyretin Amyloidosis Drug Picture
Figure 2. World Transthyretin Amyloidosis Drug Production Value: 2017 & 2021 & 2028, (USD Million)
Figure 3. World Transthyretin Amyloidosis Drug Production Value and Forecast (2017-2028) & (USD Million)
Figure 4. World Transthyretin Amyloidosis Drug Production (2017-2028) & (K Units)
Figure 5. World Transthyretin Amyloidosis Drug Average Price (2017-2028) & (US$/Unit)
Figure 6. World Transthyretin Amyloidosis Drug Production Value Market Share by Region (2017-2028)
Figure 7. World Transthyretin Amyloidosis Drug Production Market Share by Region (2017-2028)
Figure 8. North America Transthyretin Amyloidosis Drug Production (2017-2028) & (K Units)
Figure 9. Europe Transthyretin Amyloidosis Drug Production (2017-2028) & (K Units)
Figure 10. China Transthyretin Amyloidosis Drug Production (2017-2028) & (K Units)
Figure 11. Japan Transthyretin Amyloidosis Drug Production (2017-2028) & (K Units)
Figure 12. Transthyretin Amyloidosis Drug Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Transthyretin Amyloidosis Drug Demand (2017-2028) & (K Units)
Figure 15. World Transthyretin Amyloidosis Drug Consumption Market Share by Region (2017-2028)
Figure 16. United States Transthyretin Amyloidosis Drug Consumption (2017-2028) & (K Units)
Figure 17. China Transthyretin Amyloidosis Drug Consumption (2017-2028) & (K Units)
Figure 18. Europe Transthyretin Amyloidosis Drug Consumption (2017-2028) & (K Units)
Figure 19. Japan Transthyretin Amyloidosis Drug Consumption (2017-2028) & (K Units)
Figure 20. South Korea Transthyretin Amyloidosis Drug Consumption (2017-2028) & (K Units)
Figure 21. ASEAN Transthyretin Amyloidosis Drug Consumption (2017-2028) & (K Units)
Figure 22. India Transthyretin Amyloidosis Drug Consumption (2017-2028) & (K Units)
Figure 23. Producer Shipments of Transthyretin Amyloidosis Drug by Manufacturer Revenue ($MM) and Market Share (%): 2021
Figure 24. Global Four-firm Concentration Ratios (CR4) for Transthyretin Amyloidosis Drug Markets in 2021
Figure 25. Global Four-firm Concentration Ratios (CR8) for Transthyretin Amyloidosis Drug Markets in 2021
Figure 26. United States VS China: Transthyretin Amyloidosis Drug Production Value Market Share Comparison (2017 & 2021 & 2028)
Figure 27. United States VS China: Transthyretin Amyloidosis Drug Production Market Share Comparison (2017 & 2021 & 2028)
Figure 28. United States VS China: Transthyretin Amyloidosis Drug Consumption Market Share Comparison (2017 & 2021 & 2028)
Figure 29. Key Producers and Market Share of Transthyretin Amyloidosis Drug in United States
Figure 30. Key Producers and Market Share of Transthyretin Amyloidosis Drug in China
Figure 31. Key Producers and Market Share of Transthyretin Amyloidosis Drug in Rest of World
Figure 32. World Transthyretin Amyloidosis Drug Production Value by Type, (USD Million), 2017 & 2021 & 2028
Figure 33. World Transthyretin Amyloidosis Drug Production Value Market Share by Type in 2021
Figure 34. Tafamidis
Figure 35. Patisiran
Figure 36. Inotersen
Figure 37. Other
Figure 38. World Transthyretin Amyloidosis Drug Production Market Share by Type (2017-2028)
Figure 39. World Transthyretin Amyloidosis Drug Production Value Market Share by Type (2017-2028)
Figure 40. World Transthyretin Amyloidosis Drug Average Price by Type (2017-2028) & (US$/Unit)
Figure 41. World Transthyretin Amyloidosis Drug Production Value by Application, (USD Million), 2017 & 2021 & 2028
Figure 42. World Transthyretin Amyloidosis Drug Production Value Market Share by Application in 2021
Figure 43. Hereditary Transthyretin Amyloidosis
Figure 44. Wild Transthyretin Amyloidosis
Figure 45. World Transthyretin Amyloidosis Drug Production Market Share by Application (2017-2028)
Figure 46. World Transthyretin Amyloidosis Drug Production Value Market Share by Application (2017-2028)
Figure 47. World Transthyretin Amyloidosis Drug Average Price by Application (2017-2028) & (US$/Unit)
Figure 48. Manufacturing Cost Structure Analysis of Transthyretin Amyloidosis Drug in 2021
Figure 49. Manufacturing Process Analysis of Transthyretin Amyloidosis Drug
Figure 50. Transthyretin Amyloidosis Drug Industrial Chain
Figure 51. Distribution Channel Breakdown for Transthyretin Amyloidosis Drug Shipments (%): 2017-2028
Figure 52. Direct Channel Pros & Cons
Figure 53. Indirect Channel Pros & Cons
Figure 54. Methodology
Figure 55. Research Process and Data Source
